Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071032 · ClinicalTrials.gov registry record · Phase 3
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,016
- Enrollment target
NCT00071032 is a Phase 3 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 2,016 participants.
The verdict
NCT00071032, a Phase 3 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,016 participants
- Enrollment target
Study Summary
The purpose of this study is to compare liberal red blood cell transfusion therapy with restrictive red blood cell transfusion therapy in surgical patients with cardiovascular disease or risk factors.
Interventions
- BIOLOGICAL Liberal (10 g/dL) Transfusion Strategy
- BIOLOGICAL Restrictive (Symptomatic) Transfusion Strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,016 participants |
| Start Date | 2003-07 |
| Est. Completion | 2009-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00071032
The ClinicalTrials.gov registry entry for NCT00071032 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,016 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Liberal (10 g/dL) Transfusion Strategy is the first listed.
NCT00071032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00071032 about?
NCT00071032 is a clinical study titled "Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease". The purpose of this study is to compare liberal red blood cell transfusion therapy with restrictive red blood cell transfusion therapy in surgical patients with cardiovascular disease or risk factors.
What is the current status of trial NCT00071032?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,016 participants. The study started on 2003-07. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00071032?
The interventions under investigation include: Liberal (10 g/dL) Transfusion Strategy (BIOLOGICAL), Restrictive (Symptomatic) Transfusion Strategy (BIOLOGICAL).
Who is sponsoring clinical trial NCT00071032?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.